Kinnate
is a California-based biopharmaceutical company that researches and develops small-molecule therapeutics for the treatment of cancer... Read moreKinnate
is a California-based biopharmaceutical company that researches and develops small-molecule therapeutics for the treatment of cancer... Read more
2018
PublicAcquired by XOMA CorporationNASDAQKNTE
News
Jun 13, 2024
Marketscreener
Kinnate: Kinnate Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr 03, 2024
BioSpace
Kinnate: XOMA Corporation Announces Closing of Tender Offer
Apr 03, 2024
MarketScreener
Kinnate: XOMA : Acquisition/Asset Disposal - Form 8-K
Mar 28, 2024
Marketscreener
Kinnate: Kinnate Biopharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar 19, 2024
BioSpace
Kinnate: XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
Mar 04, 2024
European Biotechnology
Kinnate: Pierre Fabre SAS in US$31m licence deal with Kinnate Biopharma Inc
Mar 01, 2024
RTTNews
Kinnate: Kinnate Biopharma Sells Exarafenib To Pierre Fabre Laboratories - Quick Facts
Feb 19, 2024
Acrofan
Kinnate: KINNATE BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Pro
Feb 16, 2024
Benzinga
Kinnate: Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma
Feb 16, 2024
centralcharts
Press Release: Kinnate : Shareholder Alert: Ademi LLP investigates whether Kinnate Biopharma Inc. has obtained a Fair Price in its transaction with XOMA
Kinnate Competitors
1
2
3
4
5
6
7
8
9
10